GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Minority Interest

Artrya (ASX:AYA) Minority Interest : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Artrya Minority Interest?

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Artrya's minority interest for the quarter that ended in Dec. 2024 was A$0.00 Mil.


Artrya Minority Interest Historical Data

The historical data trend for Artrya's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Minority Interest Chart

Artrya Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Minority Interest
- - - -

Artrya Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Minority Interest Get a 7-Day Free Trial - - - - -

Artrya Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.


Artrya Business Description

Traded in Other Exchanges
N/A
Address
1257 Hay Street, West Perth, Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines